NCT02537834View on ClinicalTrials.gov

Tofogliflozin GLP-1 Analogue Combination Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

October 31, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Tofogliflozin

DRUG

GLP-1 analogue

Trial Locations (11)

456-0058

Atsuta-ku

455-0018

Minato-ku

292-0038

Kisarazu

379-0116

Annaka

311-0113

Naka

252-0302

Sagamihara

714-0043

Kasaoka

329-0433

Shimono

123-0845

Adachi-ku

103-0027

Chuo-ku

181-0013

Mitaka

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Kowa Company, Ltd.

INDUSTRY